http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004067022-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a93fbcd6f911a057e944147aa64593ec
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
filingDate 2004-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fbd7151ce1ab632f91418fd5337de70
publicationDate 2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004067022-A2
titleOfInvention Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour
abstract The invention relates to the use of pharmaceutical agents that combine neuropeptides, ideally oxytocin, and steroids such as androgens, oestrogens and progestational hormones for treating disturbances of psychosocial behaviour and experiences.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011252764-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011140608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709756-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3532031-A4
priorityDate 2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5550120-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9843660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5582592-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226457370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128159095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57079521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14653378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403922

Total number of triples: 44.